Virios Therapeutics Announces Initial FDA Feedback on
-Virios’ IMC-1 Phase 3 Proposed Program is Considered Acceptable based on Initial FDA Feedback Pending Review of the Final Chronic Toxicology Program...
Virios Therapeutics Inc Program Is Considered Acceptable Exchange Commission Company Phase Us Food Drug Administration Program Proposal
Source: globenewswire.com